AKT1 and breast cancer: It has been shown to interact with protein arginase methyltransferase 5 (PRMT5), leading to enhanced transcription of stanniocalcin-l (STC-1), a factor that can activate PI3K/AKT pathway and thereby promote breast cancer cell invasion [80, 81].